For example, treating mice fed an HFD with CB2 agonists enhanced hepatic steatosis and insulin resistance [93], while CB2 deficiency in the liver could alleviate HFD-induced hepatic inflammation and improve insulin resistance [94]. The gene discussed is CNR2; the disease is fatty liver disease.